Dress, it looks like the drug failed because of the adverse side effects in 80% of patients. Brother we didn't get to skip Phase 2 for no reason at all. Anyone selling because of another companies bad news could miss out. There isn't many companies in the Phase 3 trials. I think we are still okay here.
This is why RVV is tanking if Regeneron Arthritis drug failed I'm losing hope on this ticker. Hopefully the IND doesn't get delayed or this will really tank hard. I knew I should sold between .40-.50 always lock in profits and don't fall in love with a stock or it's story.
A Multicentre Trial of Bucillamine in the Treatment of Early Rheumatoid Arthritis (SNOW Study)
Regeneron Pharmaceuticals Inc and Sanofi their drug Kevzara failed to meet the main goals of a U.S. Doesn't mean Bucillamine fail too. Chit look at the side effects KEVZARA it's easy to tell why KEVZARA won't work. On other hand Bucillamine the drug works by helping restore and enhance an antioxidant called glutathione. Revive has a history of repurposing drugs and IP such as Bucillamine, a cysteine that has been used for more than 30 years with an impeccable track record for safety.
KEVZARA® (sarilumab) can cause serious side effects including: SERIOUS INFECTIONS: KEVZARA is a medicine that affects your immune system. KEVZARA can lower the ability of your immune system to fight infections. Some people have had serious infections while using KEVZARA, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider should test you for TB before starting KEVZARA. Your healthcare provider should monitor you closely for signs and symptoms of TB during treatment with KEVZARA.
Bucillamine: A Potent Thiol Donor with Multiple Clinical Applications:
Bucillamine is an antirheumatic agent developed from tiopronin. It is mainly used in Japan and Korea. Activity is mediated by the two thiol groups that the molecule contains. Research done in USA showed positive transplant preservation https://en.wikipedia.org/wiki/Bucillamine
Case study: "until recently there has been no report on an association between BOOP and bucillamine. We describe a patient with RA who developed BOOP during the treatment of bucillamine. http://www.kjim.org/journal/view.php?number=8022